Tomoki Ichijima

A multicenter, open-label, uncontrolled, single-arm phase 2 study of tirabrutinib, an oral Bruton’s tyrosine kinase inhibitor, in pemphigus

Jun Yamagami, Hideyuki Ujiie, Yumi Aoyama et al. · Journal of Dermatological Science · 2021 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

IL-1.BETA. Genotype-Related Effect of Prednisolone on IL-1.BETA. Production in Human Peripheral Blood Mononuclear Cells under Acute Inflammation

Svetlana Markova, Tsutomu Nakamura, Hiroo Makimoto et al. · Biological and Pharmaceutical Bulletin · 2007 · 12 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Effectiveness of protocol-based pharmacotherapy management collaboration between hospital and community pharmacists to address capecitabine-related hand–foot syndrome in cancer patients: a retrospective study

Nobuhiko Nakamura, Hiroki Shiraiwa, Yasuhiro Haruna et al. · Journal of Pharmaceutical Health Care and Sciences · 2021 · 10 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17